Sygnature Discovery

We are a world-leading integrated drug discovery and non-clinical solutions provider, driven by our passion for science and the profound impact of our work. Since our inception in 2004, our mission has been to accelerate the discovery of new medicines, transforming laboratory breakthroughs into life-changing treatments for patients with unmet medical needs. We believe in doing drug discovery better, and it's this ethos that has guided our growth from a small team of medicinal chemists to a global organization of over 1,000 employees, including 900 dedicated scientists. Our work is not just about the science; it's about people. The battle against disease is a challenge we meet head-on every day, powered by our love for scientific exploration and the immense value of what we create.

Our approach is built on a foundation of true collaboration and integration. We pride ourselves on becoming an extension of our clients' teams, working transparently and synergistically to drive projects forward. Our unique co-located model, with multidisciplinary teams of chemists, biologists, DMPK specialists, and computational scientists working side-by-side in our state-of-the-art facilities in the UK and Canada, is key to our success. This close collaboration fosters the innovation and problem-solving needed to overcome the inevitable hurdles in drug discovery. We've invested heavily in our people and our facilities because we know that creating a culture of excellence, where talented and enthusiastic scientists can thrive, is paramount. It's this commitment that has enabled us to deliver over 40 pre-clinical compounds and 22 clinical compounds, making a tangible difference in the journey to develop the medicines of tomorrow.